Table 1 Demographics, clinical characteristics, and biomarker information of the study population
Characteristics | Total group, n = 154 | Amyloid status CSF | |
|---|---|---|---|
Aβ positive, n = 42 (27.3%) | Aβ negative, n = 112 (72.7%) | ||
Age, years | 72.1 [65; 86] | 73.7 [65; 85] | 71.4 [65; 86] |
Female gender | 49 (31.8 %) | 13 (30.6%) | 36 (32.1%) |
MMSE | 29 (25–30) | 29 (25–30) | 29 (25–30) |
GDS | 0 (0–5) | 1 (0–5) | 0 (0–5) |
CDR | 0.0 (0–0.5) | 0.0 (0) | 0.0 (0–0.5) |
IADL | 0.0 (0) | 0.0 (0) | 0.0 (0) |
Educationa | 6 (1–7) | 6 (1–7) | 6 (1–7) |
Apoe e4/e4 (n = 150) | 5 (3.3%) | 5 (100%) | 0 (0%) |
Apoe at least one e4 allele (n = 150) | 39 (26%) | 18 (42.9%) | 21 (18.8%) |